1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results for "Multiple Myeloma (MM)".

MM - 144

Rising Mortality from Multiple Myeloma-Associated Heart Failure in Older US Adults: A CDC WONDER Analysis (1999-2024)

Osama Mohiuddin

Poster Presenter: Osama Mohiuddin

$Thumbnail for Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis$

MM - 1441

Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

Faiza Khalid

Poster Presenter: Faiza Khalid

SOHO 2026 Annual Meeting

Topics

Rising Mortality from Multiple Myeloma-Associated Heart Failure in Older US Adults: A CDC WONDER Analysis (1999-2024)

Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

Second Primary Malignancies in Multiple Myeloma: A Retrospective Population-Based Analysis

Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma

Daratumumab-Based Treatment Strategies with Daratumumab-Lenalidomide Maintenance vs Lenalidomide Maintenance in Transplant Eligible NDMM: A Systematic Review and Meta-Analysis

Comparative Evaluation of Large Language Models (LLMs) for Guideline-Concordant Therapy Selection in Multiple Myeloma: A Cross-Sectional Assessment of ChatGPT, Claude, and Gemini

Infection-Fatality Phenotype of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Target-Stratified Systematic Review and Meta-Analysis

Overall Survival With Anti-BCMA Therapies: Indirect Comparison of Belantamab Mafodotin/Bortezomib/Dexamethasone (BVd) vs Teclistamab/Daratumumab (Tec-Dara) in Relapsed/Refractory Multiple Myeloma

Efficacy and Safety of CAR-T Cell Therapy in Plasma Cell Leukemia: A Systematic Review and Meta-Analysis